Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 3/2023

16.08.2022 | Original Paper

Bridge centrality network structure of negative symptoms in people with schizophrenia

verfasst von: Ling-ling Wang, Michelle H. W. Tam, Karen K. Y. Ho, Karen S. Y. Hung, Jessica O. Y. Wong, Simon S. Y. Lui, Raymond C. K. Chan

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Negative symptoms are complex psychopathology. Although evidence generally supported the NIMH five consensus domains, research seldom examined measurement invariance of this model, and domain-specific correspondence across multiple scales. This study aimed to examine the interrelationship between negative symptom domains captured by different rating scales, and to examine the domain-specific correspondence across multiple scales. We administered the Brief Negative Symptom Scale (BNSS), the Self-evaluation of Negative Symptoms (SNS), and the Scale for Assessment of Negative Symptoms (SANS) to 204 individuals with schizophrenia. We used network analysis to examine the interrelationship between negative symptom domains. Besides regularized partial correlation network, we estimated bridge centrality indices to investigate domain-specific correspondence, while taking each scale as an independent community. The regularized partial correlation network showed that the SNS nodes clustered together, whereas the SANS and the BNSS nodes intermingled together. The SANS attention domain lied at the periphery of the network according to the Fruchterman–Reingold algorithm. The SANS anhedonia–asociality (strength = 1.48; EI = 1.48) and the SANS affective flattening (strength = 1.06; EI = 1.06) had the highest node strength and EI. Moreover, the five nodes of the BNSS bridged the nodes of the SANS and the SNS. BNSS blunted affect (strength = 0.76; EI = 0.76) and SANS anhedonia–asociality (strength = 0.76; EI = 0.74) showed the highest bridge strength and bridge EI. The BNSS captures negative symptoms and bridges the symptom domains measured by the SANS and the SNS. The three scales showed domain-specific correspondence.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Kirkpatrick B, Strauss GP, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A, Marder SR (2011) The brief negative symptom scale: psychometric properties. Schizophr Bull 37(2):300–305CrossRefPubMed Kirkpatrick B, Strauss GP, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A, Marder SR (2011) The brief negative symptom scale: psychometric properties. Schizophr Bull 37(2):300–305CrossRefPubMed
5.
Zurück zum Zitat Lincoln TM, Dollfus S, Lyne J (2017) Current developments and challenges in the assessment of negative symptoms. Schizophr Res 186:8–18CrossRefPubMed Lincoln TM, Dollfus S, Lyne J (2017) Current developments and challenges in the assessment of negative symptoms. Schizophr Res 186:8–18CrossRefPubMed
6.
Zurück zum Zitat Andreasen NC (1989) The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl 7:49–58CrossRef Andreasen NC (1989) The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl 7:49–58CrossRef
11.
Zurück zum Zitat Ahmed AO, Kirkpatrick B, Galderisi S, Mucci A, Rossi A, Bertolino A, Rocca P, Maj M, Kaiser S, Bischof M, Hartmann-Riemer MN, Kirschner M, Schneider K, Garcia-Portilla MP, Mane A, Bernardo M, Fernandez-Egea E, Jiefeng C, Jing Y et al (2019) Cross-cultural validation of the 5-factor structure of negative symptoms in schizophrenia. Schizophr Bull 45(2):305–314. https://doi.org/10.1093/schbul/sby050CrossRefPubMed Ahmed AO, Kirkpatrick B, Galderisi S, Mucci A, Rossi A, Bertolino A, Rocca P, Maj M, Kaiser S, Bischof M, Hartmann-Riemer MN, Kirschner M, Schneider K, Garcia-Portilla MP, Mane A, Bernardo M, Fernandez-Egea E, Jiefeng C, Jing Y et al (2019) Cross-cultural validation of the 5-factor structure of negative symptoms in schizophrenia. Schizophr Bull 45(2):305–314. https://​doi.​org/​10.​1093/​schbul/​sby050CrossRefPubMed
12.
Zurück zum Zitat Mucci A, Vignapiano A, Bitter I, Austin SF, Delouche C, Dollfus S, Erfurth A, Fleischhacker WW, Giordano GM, Gladyshev I, Glenthøj B, Gütter K, Hofer A, Hubeňák J, Kaiser S, Libiger J, Melle I, Nielsen MØ, Papsuev O et al (2019) A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale. Eur Neuropsychopharmacol 29(8):947–959. https://doi.org/10.1016/j.euroneuro.2019.05.006CrossRefPubMed Mucci A, Vignapiano A, Bitter I, Austin SF, Delouche C, Dollfus S, Erfurth A, Fleischhacker WW, Giordano GM, Gladyshev I, Glenthøj B, Gütter K, Hofer A, Hubeňák J, Kaiser S, Libiger J, Melle I, Nielsen MØ, Papsuev O et al (2019) A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale. Eur Neuropsychopharmacol 29(8):947–959. https://​doi.​org/​10.​1016/​j.​euroneuro.​2019.​05.​006CrossRefPubMed
17.
Zurück zum Zitat Borsboom D, Cramer AO (2013) Network analysis: an integrative approach to the structure of psychopathology. Annu Rev Clin Psychol 9:91–121CrossRefPubMed Borsboom D, Cramer AO (2013) Network analysis: an integrative approach to the structure of psychopathology. Annu Rev Clin Psychol 9:91–121CrossRefPubMed
18.
21.
Zurück zum Zitat Strauss GP, Esfahlani FZ, Kirkpatrick B, Allen DN, Gold JM, Visser KF, Sayama H (2019) Network analysis reveals which negative symptom domains are most central in schizophrenia vs bipolar disorder. Schizophr Bull 45(6):1319–1330CrossRefPubMedPubMedCentral Strauss GP, Esfahlani FZ, Kirkpatrick B, Allen DN, Gold JM, Visser KF, Sayama H (2019) Network analysis reveals which negative symptom domains are most central in schizophrenia vs bipolar disorder. Schizophr Bull 45(6):1319–1330CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Strauss GP, Zamani Esfahlani F, Sayama H, Kirkpatrick B, Opler MG, Saoud JB, Davidson M, Luthringer R (2020) Network analysis indicates that avolition is the most central domain for the successful treatment of negative symptoms: evidence from the roluperidone randomized clinical trial. Schizophrenia Bull. https://doi.org/10.1093/schbul/sbz141CrossRef Strauss GP, Zamani Esfahlani F, Sayama H, Kirkpatrick B, Opler MG, Saoud JB, Davidson M, Luthringer R (2020) Network analysis indicates that avolition is the most central domain for the successful treatment of negative symptoms: evidence from the roluperidone randomized clinical trial. Schizophrenia Bull. https://​doi.​org/​10.​1093/​schbul/​sbz141CrossRef
23.
Zurück zum Zitat Levine SZ, Leucht S (2016) Identifying a system of predominant negative symptoms: network analysis of three randomized clinical trials. Schizophr Res 178(1–3):17–22CrossRefPubMed Levine SZ, Leucht S (2016) Identifying a system of predominant negative symptoms: network analysis of three randomized clinical trials. Schizophr Res 178(1–3):17–22CrossRefPubMed
24.
Zurück zum Zitat Chang WC, Wong CSM, Or PCF, Chu AOK, Hui CLM, Chan SKW, Lee EMH, Suen YN, Chen EYH (2020) Inter-relationships among psychopathology, premorbid adjustment, cognition and psychosocial functioning in first-episode psychosis: a network analysis approach. Psychol Med 50(12):2019–2027CrossRefPubMed Chang WC, Wong CSM, Or PCF, Chu AOK, Hui CLM, Chan SKW, Lee EMH, Suen YN, Chen EYH (2020) Inter-relationships among psychopathology, premorbid adjustment, cognition and psychosocial functioning in first-episode psychosis: a network analysis approach. Psychol Med 50(12):2019–2027CrossRefPubMed
25.
Zurück zum Zitat Haguiara B, Koga G, Diniz E, Fonseca L, Higuchi CH, Kagan S, Lacerda A, Correll CU, Gadelha A (2021) What is the best latent structure of negative symptoms in schizophrenia? A systematic review. Schizophrenia Bull Open 2(1):sgab013CrossRef Haguiara B, Koga G, Diniz E, Fonseca L, Higuchi CH, Kagan S, Lacerda A, Correll CU, Gadelha A (2021) What is the best latent structure of negative symptoms in schizophrenia? A systematic review. Schizophrenia Bull Open 2(1):sgab013CrossRef
26.
Zurück zum Zitat Dollfus S, Mach C, Morello R (2016) Self-evaluation of negative symptoms: a novel tool to assess negative symptoms. Schizophr Bull 42(3):571–578CrossRefPubMed Dollfus S, Mach C, Morello R (2016) Self-evaluation of negative symptoms: a novel tool to assess negative symptoms. Schizophr Bull 42(3):571–578CrossRefPubMed
28.
Zurück zum Zitat Wang L-L, Lui SS, Chan RC (2022) The past and future of mapping the biomarkers of psychosis. Curr Opin Behav Sci 43:1–5CrossRef Wang L-L, Lui SS, Chan RC (2022) The past and future of mapping the biomarkers of psychosis. Curr Opin Behav Sci 43:1–5CrossRef
30.
Zurück zum Zitat Wang Y, Hu Z, Feng Y, Wilson A, Chen R (2020) Changes in network centrality of psychopathology symptoms between the COVID-19 outbreak and after peak. Mol Psychiatry 25(12):3140–3149CrossRefPubMedPubMedCentral Wang Y, Hu Z, Feng Y, Wilson A, Chen R (2020) Changes in network centrality of psychopathology symptoms between the COVID-19 outbreak and after peak. Mol Psychiatry 25(12):3140–3149CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Llerena K, Park SG, McCarthy JM, Couture SM, Bennett ME, Blanchard JJ (2013) The Motivation and Pleasure Scale–Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms. Compr Psychiatry 54(5):568–574CrossRefPubMedPubMedCentral Llerena K, Park SG, McCarthy JM, Couture SM, Bennett ME, Blanchard JJ (2013) The Motivation and Pleasure Scale–Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms. Compr Psychiatry 54(5):568–574CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Publishing, Inc, Washington DC, pp xxvii, 886 American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Publishing, Inc, Washington DC, pp xxvii, 886
34.
Zurück zum Zitat First MB (1997) User’s guide for the structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version. American Psychiatric Pub, Washington DC First MB (1997) User’s guide for the structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version. American Psychiatric Pub, Washington DC
35.
Zurück zum Zitat Kay S, R, Fiszbein, A., & Opler, L. A. (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276CrossRefPubMed Kay S, R, Fiszbein, A., & Opler, L. A. (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276CrossRefPubMed
37.
39.
Zurück zum Zitat Leucht S, Samara M, Heres S, Davis JM (2016) Dose equivalents for antipsychotic drugs: the DDD method. Schizophrenia Bull 42(suppl_1):S90–S94CrossRef Leucht S, Samara M, Heres S, Davis JM (2016) Dose equivalents for antipsychotic drugs: the DDD method. Schizophrenia Bull 42(suppl_1):S90–S94CrossRef
40.
Zurück zum Zitat Fruchterman TMJ, Reingold EM (1991) Graph drawing by force-directed placement. Software Practice Experience 21(11):1129–1164CrossRef Fruchterman TMJ, Reingold EM (1991) Graph drawing by force-directed placement. Software Practice Experience 21(11):1129–1164CrossRef
49.
Zurück zum Zitat Fervaha G, Foussias G, Agid O, Remington G (2014) Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia. Acta Psychiatr Scand 130(4):290–299CrossRefPubMed Fervaha G, Foussias G, Agid O, Remington G (2014) Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia. Acta Psychiatr Scand 130(4):290–299CrossRefPubMed
50.
Zurück zum Zitat Kaliuzhna M, Kirschner M, Carruzzo F, Hartmann-Riemer MN, Bischof M, Seifritz E, Tobler PN, Kaiser S (2020) Clinical, behavioural and neural validation of the PANSS amotivation factor. Schizophr Res 220:38–45CrossRefPubMed Kaliuzhna M, Kirschner M, Carruzzo F, Hartmann-Riemer MN, Bischof M, Seifritz E, Tobler PN, Kaiser S (2020) Clinical, behavioural and neural validation of the PANSS amotivation factor. Schizophr Res 220:38–45CrossRefPubMed
51.
Zurück zum Zitat Liemburg E, Castelein S, Stewart R, van der Gaag M, Aleman A, Knegtering H, Genetic Risk and Outcome of Psychosis (GROUP) Investigators (2013) Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. J Psychiatr Res 47(6):718–725CrossRefPubMed Liemburg E, Castelein S, Stewart R, van der Gaag M, Aleman A, Knegtering H, Genetic Risk and Outcome of Psychosis (GROUP) Investigators (2013) Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. J Psychiatr Res 47(6):718–725CrossRefPubMed
Metadaten
Titel
Bridge centrality network structure of negative symptoms in people with schizophrenia
verfasst von
Ling-ling Wang
Michelle H. W. Tam
Karen K. Y. Ho
Karen S. Y. Hung
Jessica O. Y. Wong
Simon S. Y. Lui
Raymond C. K. Chan
Publikationsdatum
16.08.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 3/2023
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-022-01474-w

Weitere Artikel der Ausgabe 3/2023

European Archives of Psychiatry and Clinical Neuroscience 3/2023 Zur Ausgabe

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.